BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28657656)

  • 1. Functional interrelationship between TFII-I and E2F transcription factors at specific cell cycle gene loci.
    Shen Y; Nar R; Fan AX; Aryan M; Hossain MA; Gurumurthy A; Wassel PC; Tang M; Lu J; Strouboulis J; Bungert J
    J Cell Biochem; 2018 Jan; 119(1):712-722. PubMed ID: 28657656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-assisted identification of cell cycle-related genes: new targets for E2F transcription factors.
    Kel AE; Kel-Margoulis OV; Farnham PJ; Bartley SM; Wingender E; Zhang MQ
    J Mol Biol; 2001 May; 309(1):99-120. PubMed ID: 11491305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2Fs link the control of G1/S and G2/M transcription.
    Zhu W; Giangrande PH; Nevins JR
    EMBO J; 2004 Nov; 23(23):4615-26. PubMed ID: 15510213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genomics on MCM8 orthologous genes reveals the transcriptional regulation by transcription factor E2F.
    Hayashi R; Goto Y; Haga A; Kobayashi D; Ikeda R; Yoshida K
    Gene; 2006 Feb; 367():126-34. PubMed ID: 16325355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E2F transcription factor family regulates CENH3 expression in Arabidopsis thaliana.
    Heckmann S; Lermontova I; Berckmans B; De Veylder L; Bäumlein H; Schubert I
    Plant J; 2011 Nov; 68(4):646-56. PubMed ID: 21771121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
    Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
    Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of TFII-I-dependent cell cycle regulation by p53.
    Desgranges ZP; Ahn J; Lazebnik MB; Ashworth T; Lee C; Pestell RC; Rosenberg N; Prives C; Roy AL
    Mol Cell Biol; 2005 Dec; 25(24):10940-52. PubMed ID: 16314517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive and negative regulation of the transforming growth factor beta/activin target gene goosecoid by the TFII-I family of transcription factors.
    Ku M; Sokol SY; Wu J; Tussie-Luna MI; Roy AL; Hata A
    Mol Cell Biol; 2005 Aug; 25(16):7144-57. PubMed ID: 16055724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic and proteomic analysis of transcription factor TFII-I reveals insight into the response to cellular stress.
    Fan AX; Papadopoulos GL; Hossain MA; Lin IJ; Hu J; Tang TM; Kilberg MS; Renne R; Strouboulis J; Bungert J
    Nucleic Acids Res; 2014 Jul; 42(12):7625-41. PubMed ID: 24875474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal repression of BRCA1 by multiple E2Fs and pocket proteins at adjacent E2F sites.
    Bindra RS; Glazer PM
    Cancer Biol Ther; 2006 Oct; 5(10):1400-7. PubMed ID: 17106239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex.
    Rayman JB; Takahashi Y; Indjeian VB; Dannenberg JH; Catchpole S; Watson RJ; te Riele H; Dynlacht BD
    Genes Dev; 2002 Apr; 16(8):933-47. PubMed ID: 11959842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members.
    Xu X; Bieda M; Jin VX; Rabinovich A; Oberley MJ; Green R; Farnham PJ
    Genome Res; 2007 Nov; 17(11):1550-61. PubMed ID: 17908821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells.
    Tavner F; Frampton J; Watson RJ
    Oncogene; 2007 Apr; 26(19):2727-35. PubMed ID: 17072340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H; Iavarone A; Reeves SA
    Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct capacities of individual E2Fs to induce cell cycle re-entry in postmitotic lens fiber cells of transgenic mice.
    Chen Q; Liang D; Yang T; Leone G; Overbeek PA
    Dev Neurosci; 2004; 26(5-6):435-45. PubMed ID: 15855772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F in vivo binding specificity: comparison of consensus versus nonconsensus binding sites.
    Rabinovich A; Jin VX; Rabinovich R; Xu X; Farnham PJ
    Genome Res; 2008 Nov; 18(11):1763-77. PubMed ID: 18836037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F Transcription Factors Control the Roller Coaster Ride of Cell Cycle Gene Expression.
    Thurlings I; de Bruin A
    Methods Mol Biol; 2016; 1342():71-88. PubMed ID: 26254918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Interaction between TFII-I and Mdm2 with a Negative Effect on TFII-I Transcriptional Activity.
    Cetkovská K; Šustová H; Kosztyu P; Uldrijan S
    PLoS One; 2015; 10(12):e0144753. PubMed ID: 26656605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.